# CVE-2025-32383: MaxKB has a reverse shell vulnerability in function library

> Privileged users can execute arbitrary code via reverse shell in the function library module of MaxKB.

- **Severity:** Medium 4.3 (`CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:L/I:L/A:L`)
- **Exploited in the wild:** Not known
- **Login needed:** An administrator
- **Attackable:** Over the internet
- **Victim action needed:** A user has to click or open something
- **Fix available:** No
- **Published:** 10 Apr 2025
- **Updated:** 10 Apr 2025
- **Also known as:** GHSA-fjf6-6cvf-xr72

## What is CVE-2025-32383?

CVE-2025-32383 is a medium-severity code injection vulnerability in 1Panel-dev MaxKB, published on 10 Apr 2025. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link.

### Official description

MaxKB (Max Knowledge Base) is an open source knowledge base question-answering system based on a large language model and retrieval-augmented generation (RAG). A reverse shell vulnerability exists in the module of function library. The vulnerability allow privileged‌ users to create a reverse shell. This vulnerability is fixed in v1.10.4-lts.

Weakness: CWE-94 (Improper Control of Generation of Code)

## Which versions are affected by CVE-2025-32383?

It affects 1 product.


Products: Maxkb Maxkb.

## How do I fix CVE-2025-32383?

No fix has been published for CVE-2025-32383 yet. Limit exposure of the affected software until one is available.

## Is CVE-2025-32383 being exploited?

It is not confirmed as exploited in the wild, but public exploit code for CVE-2025-32383 exists.

## Other vulnerabilities in 1Panel-dev MaxKB

- [CVE-2025-66419](https://insights.sbomify.com/CVE-2025-66419/): MaxKB vulnerable to privilege escalation through sandbox bypass (high 8.8)
- [CVE-2025-66446](https://insights.sbomify.com/CVE-2025-66446/): MaxKB has a Python sandbox LD_PRELOAD bypass (high 8.8)
- [CVE-2025-64511](https://insights.sbomify.com/CVE-2025-64511/): MaxKB has SSRF in sandbox (high 7.4)
- [CVE-2026-39422](https://insights.sbomify.com/CVE-2026-39422/): MaxKB has Stored XSS via ChatHeadersMiddleware (medium 6.9)
- [CVE-2026-39423](https://insights.sbomify.com/CVE-2026-39423/): Stored XSS via Eval Injection in EchartsRander Component (medium 6.9)

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2025-32383 and fix it if it is affected.

What it is: CVE-2025-32383 is a medium-severity code injection vulnerability in 1Panel-dev MaxKB, published on 10 Apr 2025. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link.
Exploitation: It is not confirmed as exploited in the wild, but public exploit code for CVE-2025-32383 exists.

Affected product: 1Panel-dev MaxKB. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2025-32383/ (Markdown: https://insights.sbomify.com/CVE-2025-32383/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2025-32383
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2025-32383
- OSV: https://osv.dev/vulnerability/CVE-2025-32383

---
From sbomify Insights: https://insights.sbomify.com/CVE-2025-32383/
Summaries are generated and may contain mistakes; the official description above is the record.